| October 02, 2023 |
|
| |
|
|
AM Portal | Abstracts | Exhibits | onDemand | Daily News
|
| |
|
|
| |
|
Clinical Trials session highlights advances in radiation therapy that improve patient experiences, reduce health care costs
|
|
|
Moderated by Andrea Ng, MD, MPH, FASTRO, and Kenneth Rosenzweig, MD, chair and co-chair of the Annual Meeting Scientific Committee, the Clinical Trials Session consisted of eight scientifically significant trials highlighting advances in radiation therapy that improve patient experiences and reduce health care costs. Read more.
|
|
| |
|
Plenary Session preview
|
|
Today’s Plenary Session will feature five of this year’s top abstracts. The Plenary will be held in Ballroom 20 at 1:30 p.m. Attendees will first hear from Vinai Gondi, MD, who will present the late-breaking study, “Primary Endpoint Results of NRG CC003: Phase IIR/III Trial of Prophylactic Cranial Irradiation (PCI) with or without Hippocampal Avoidance (HA) for Small Cell Lung Cancer (SCLC).” This will be followed by a presentation by Jiayi Yu, PhD, titled “High Dose Hyperfractionated Thoracic Radiotherapy vs. Standard Dose for Limited Stage Small-Cell Lung Cancer: A Multicenter, Open-Label Randomized, Phase 3 Trial.” Nicholas van As, MD, MBBS, will share results from a late-breaking study, “5-Year Outcomes from PACE B: An International Phase III Randomized Controlled Trial Comparing Stereotactic Body Radiotherapy (SBRT) vs. Conventionally Fractionated or Moderately Hypo Fractionated External Beam Radiotherapy for Localized Prostate Cancer.” Mitchell Machtay, MD, FASTRO, will follow this talk with the presentation of “Randomized Phase III Trial of Postoperative Radiotherapy with or without Cetuximab for Intermediate-Risk Squamous Cell Carcinoma of the Head and Neck (SCCHN): NRG/RTOG 0920.” To conclude the extremely popular Plenary session, Soren Bentzen, DSc, PhD, FASTRO, will speak about “Randomized Controlled Trial of Hypofractionated vs. Normo-fractionated Accelerated Radiation Therapy with or without Cisplatin for Locally Advanced Head and Neck Squamous Cell Carcinoma (HYPNO).”
The Plenary’s four discussants, Debra Yeboa, MD, Kristin Higgins, MD, Alejandro Berlin, MD, and Christina Chapman, MD, highly regarded experts in radiation oncology and beyond, will provide attendees with their perspectives on the implications of presented findings on current practice and future research directions. Please be sure to join us this afternoon at the Plenary Session!
|
|
| |
|
| |
|
Today’s Daily News now available
|
 |
Pick up your copy of the Monday Daily News, available throughout the convention center and at the ASTRO Resource Center. Today’s issue includes the daily schedule at a glance, reports from yesterday’s Clinical Trials session and the Presidential Symposium, an editorial on the radiation oncology workforce study and outcomes, updates from the ROI and more. If you are attending virtually, read the PDF.
|
|
| |
|
ASTRO welcomes Dr. Arif Kamal, today’s keynote speaker
|
|
Monday morning, Arif Kamal, MD, MBA, MHS, Chief Patient Officer of the American Cancer Society, will deliver our first keynote address. Dr. Kamal’s talk, “Cancer Support 3.0: A New Era in Compassion,” will address aspects of patients’ access to care and the importance of addressing their psychological well-being to achieve optimal health outcomes.
Dr. Kamal leads the American Cancer Society’s patient support objectives and the development of strategic plans to measurably improve the lives of people with cancer and their families. He oversees the organization’s cancer support, patient navigation, educational programs, patient lodging solutions, transportation services, contact center and digital patient support offerings, as well as all aspects of organizational functions that touch cancer patients across 5,000 communities around the globe. Prior to joining the American Cancer Society, Dr. Kamal served for more than 12 years as an oncologist and researcher at Duke University and the Duke Cancer Institute. He is an Associate Professor of Medicine and Population Health at the Duke University School of Medicine and served as physician quality and outcomes officer at the Duke Cancer Institute. He holds nationally recognized expertise in oncology quality assessment and palliative care.
In addition to clinical and academic pursuits at Duke Cancer Institute, Dr. Kamal co-founded Prepped Health, a company that develops innovative technology solutions to educate and engage patients facing a serious illness like cancer and their caregivers. He also holds several leadership positions within prestigious national professional organizations, has won numerous awards and is a prolific author.
|
|
| |
|
Presidential Symposium recap
|
|
|
ASTRO President Jeff Michalski, MD, MBA, FASTRO, chose this year’s meeting theme to shine a spotlight on patient perspectives and foster engagement in advancing research and clinical care. In this spirit, the Presidential Symposium emphasized the primacy of clinical trials to shape care for patients. Read more.
|
|
| |
|
Survivor Circles Celebrates 20 years of giving, Grants awarded Sunday
|
|
|
Survivor Circle was created in 2003 to honor cancer survivors by recognizing organizations that further the fight for survivorship. ASTRO has raised well over $500,000 since the inception of the program, almost wholly from the generous support of our exhibitors, 100% of which has gone to grant recipients.
Yesterday morning, ASTRO awarded this year’s recipients, Breast Cancer Angels and Cancer Support Community Los Angeles (CSCLA), with Survivor Circle Grants of $12,500 each for the services they provide. Learn more about these organizations and how they plan to use the grants to support cancer patients, and for those of you in San Diego, stop by the Survivor Circle booth where you can fold a crane to help us reach our goal of 1,000 cranes.
|
|
| |
|
|
| |
|
Introducing the new and improved RadOnc Toolbox powered by ROI
|
|
The RadOnc Toolbox has a fresh new look and overhauled content. The Radiation Oncology Institute (ROI) collaborated with Matthew Culbert, MD, and Colton Ladbury, MD, to develop a better resource to support evidence-based care by providing easy access to frequently used radiation oncology references. The redesigned RadOnc Toolbox includes links to updated ASTRO clinical guidelines, revamped dose constraints, a library of contouring resources and a collection of clinical calculators and nomograms. Download the RadOnc Toolbox app for iOS or Android or visit rotoolbox.org. Existing users of the app will be required to create a new login because a new user authentication system is being used. For any questions on this tool and the ROI, visit the ROI Booth in Hall E Lobby Ground Floor, open today from 9:00 a.m. - 5:00 p.m.
|
|
| |
|
|
| |
|
|
